Level 1 · Chapter 2Page 1
← Library Home VIROLOGY — CHAPTER 2 — COMPLETE — LEVEL 1 (MEDICAL STUDENTS)

Virology

Part 1: General Virology  ·  Part 2: Systematic Virology

2.1  General Features & Classification of Viruses

1

Introduction

  • Viruses are obligate intracellular parasites — they have no independent metabolism and cannot replicate outside a living host cell.
  • Each virus carries only one type of nucleic acid — either DNA or RNA, never both — unlike cellular organisms.
  • They are far smaller than bacteria (typically 20–300 nm) and lack ribosomes, so they must hijack the host cell's machinery to make new viral proteins.
2

Basic Structural Components

  • Genome: DNA or RNA, single- or double-stranded, linear or circular, segmented in some families.
  • Capsid: protein shell built from repeating subunits (capsomeres); protects the genome and mediates attachment in non-enveloped viruses. Common symmetries: icosahedral (spherical-looking) or helical (rod-like).
  • Nucleocapsid: genome + capsid together.
  • Envelope: a lipid bilayer some viruses acquire from the host cell membrane as they bud out; studded with viral glycoprotein spikes used for attachment.
◎

Enveloped vs. Non-Enveloped Virus

Non-enveloped (naked) e.g., Poliovirus, Norovirus Enveloped e.g., Influenza, HIV, Herpesviruses
Fig. 2.1 — Capsid (red), genome (navy dot), and envelope with glycoprotein spikes
3

Classification Basics

CriterionCategory ACategory B
Nucleic acidDNA virusesRNA viruses
EnvelopeEnvelopedNon-enveloped (naked)
Capsid symmetryIcosahedralHelical
Genome strandednessSingle-strandedDouble-stranded
✚

Clinical Correlation

ENVELOPE & DISINFECTION

Concept: The lipid envelope is fragile and easily disrupted by soap, alcohol, and detergents — which is exactly why hand washing and alcohol-based sanitizers are so effective against enveloped viruses like influenza, HIV, and coronaviruses.

Contrast: Non-enveloped viruses (e.g., norovirus, poliovirus) lack this vulnerable lipid layer and are markedly more resistant to alcohol-based disinfectants — outbreaks of norovirus are classically controlled with bleach, not hand sanitizer alone.

2.2  Viral Replication Cycle

1

The Six Steps

  • 1Attachment — viral surface proteins bind a specific host cell receptor.
  • 2Penetration — the virus enters the cell (membrane fusion for enveloped viruses, or endocytosis).
  • 3Uncoating — the capsid is removed, releasing the viral genome into the cell.
  • 4Biosynthesis — the host machinery is hijacked to transcribe and translate viral genes and replicate the genome.
  • 5Assembly — new capsids and genomes are packaged into complete virions.
  • 6Release — new virions exit by cell lysis (typically non-enveloped viruses) or budding through the membrane (enveloped viruses, which acquire their envelope this way).
2

Lysis vs. Budding Release

FeatureLysisBudding
Typical virus typeNon-envelopedEnveloped
Effect on host cellCell destroyed, dies immediatelyCell may survive, releasing virus gradually
ExamplePoliovirusInfluenza, HIV
✚

Clinical Correlation

TARGETING EACH STEP WITH DRUGS

Antiviral drugs are often designed to block a single, specific step of this cycle. For example, enfuvirtide blocks HIV's membrane fusion (penetration step), while neuraminidase inhibitors like oseltamivir block influenza's release step by preventing new virions from budding free of the cell surface.

2.3  Bacteriophages

1

Introduction

  • Bacteriophages ("phages") are viruses that infect bacteria specifically, following the same general replication logic as other viruses.
  • They follow one of two life cycles depending on the phage type and conditions: lytic or lysogenic.
2

Lytic vs. Lysogenic Cycle

FeatureLytic CycleLysogenic Cycle
OutcomeImmediate replication and cell lysisPhage DNA integrates into host chromosome (prophage)
Host cell fateDestroyedSurvives, divides normally, passes prophage to daughter cells
Trigger to become lytic—Stress (e.g., UV light) can induce excision and a switch to the lytic cycle
✚

Clinical Correlation

PHAGE CONVERSION

Concept: While integrated as a prophage, a lysogenic phage can carry bacterial toxin genes that the bacterium expresses as its own — this is exactly how diphtheria toxin (Corynebacterium diphtheriae) and cholera toxin (Vibrio cholerae) genes were originally acquired, a process called lysogenic (phage) conversion, covered in Chapter 1's bacterial genetics.

2.4  Viral Genetics & Variation

1

Sources of Viral Variation

  • Mutation: RNA viruses mutate especially fast because RNA polymerases lack proofreading ability, unlike DNA polymerases.
  • Reassortment: when a cell is co-infected by two different strains of a segmented-genome virus, entire gene segments can mix into new combinations.
  • Recombination: exchange of genetic material between two viral genomes during co-infection.
2

Antigenic Drift vs. Antigenic Shift

FeatureAntigenic DriftAntigenic Shift
MechanismGradual point mutationsSudden reassortment of gene segments
Magnitude of changeSmall, incrementalLarge, abrupt
Clinical consequenceSeasonal flu epidemicsInfluenza pandemics (novel strain, little population immunity)
✚

Clinical Correlation

WHY THE FLU VACCINE CHANGES EVERY YEAR

Influenza's segmented RNA genome and error-prone polymerase make it drift constantly, so last year's antibodies may no longer recognize this year's circulating strain — this is precisely why the seasonal influenza vaccine is reformulated annually to match predicted circulating strains.

2.5  Mechanisms of Action of Antiviral Agents

1

Classification by Target Step

Target StepDrug ClassExample Agents
Attachment/EntryFusion/entry inhibitorsEnfuvirtide, maraviroc (HIV)
UncoatingM2 ion channel blockersAmantadine (older influenza drug)
Genome replicationNucleoside/nucleotide analogsAcyclovir, tenofovir, remdesivir
Genome replicationReverse transcriptase inhibitorsZidovudine, efavirenz
Protein processingProtease inhibitorsRitonavir, lopinavir
ReleaseNeuraminidase inhibitorsOseltamivir, zanamivir
✚

Clinical Correlation

COMBINATION ANTIVIRAL THERAPY (HAART)

Concept: HIV treatment combines drugs from different mechanistic classes (e.g., a reverse transcriptase inhibitor + a protease inhibitor) rather than relying on one drug alone. Hitting multiple independent steps of the replication cycle simultaneously makes it far harder for the virus to develop resistance to the entire regimen at once — the same logic behind multi-drug tuberculosis therapy in bacteriology.

2.6  Antiviral Resistance

1

Common Resistance Mechanisms

  • 1Target enzyme mutation — mutations in reverse transcriptase or protease reduce drug binding (classic in HIV under selective drug pressure).
  • 2Reduced drug activation — some antivirals are prodrugs requiring a viral enzyme to become active; loss of that enzyme's activity blocks activation (e.g., acyclovir requires viral thymidine kinase).
  • 3Rapid mutation rate — RNA viruses' error-prone replication generates resistant variants quickly under drug pressure, similar in logic to bacterial antibiotic resistance selection.
✚

Clinical Correlation

ACYCLOVIR-RESISTANT HERPES

Mechanism: Acyclovir must first be phosphorylated by the herpesvirus's own thymidine kinase to become active. Immunocompromised patients on long-term acyclovir can select for HSV strains with a mutated or absent thymidine kinase — these strains can no longer activate the drug and become clinically resistant, usually requiring a switch to foscarnet, which does not require viral activation.

PART 2 — Systematic Virology

2.7  Herpesviruses

1

Introduction

  • Herpesviridae are large, enveloped, double-stranded DNA viruses.
  • Their hallmark biological feature is latency — after primary infection, the virus persists silently in specific host cells for life and can periodically reactivate.
2

Key Human Herpesviruses

VirusSite of LatencyClassic Disease
HSV-1Trigeminal ganglionOral herpes (cold sores), keratitis, encephalitis
HSV-2Sacral ganglionGenital herpes
Varicella-zoster (VZV)Dorsal root gangliaChickenpox (primary); shingles (reactivation)
Epstein-Barr virus (EBV)B lymphocytesInfectious mononucleosis; linked to Burkitt lymphoma
Cytomegalovirus (CMV)Monocytes, lymphocytesMononucleosis-like illness; congenital infection; disease in immunosuppressed patients
✚

Clinical Correlation

REACTIVATION TRIGGERS

Latent herpesviruses reactivate under stress, UV light exposure, fever, or immunosuppression — this is why cold sores classically recur during illness or sun exposure, and why shingles (VZV reactivation) appears decades after childhood chickenpox, often when cell-mediated immunity naturally declines with age or is suppressed by disease/medication.

2.8  Hepatitis Viruses

1

Overview

VirusGenomeTransmission
Hepatitis A (HAV)RNAFecal-oral (contaminated food/water)
Hepatitis B (HBV)DNABlood, sexual contact, perinatal
Hepatitis C (HCV)RNABlood (needles, transfusions)
Hepatitis D (HDV)RNA (defective — needs HBV)Blood, sexual contact (only with HBV co-infection)
Hepatitis E (HEV)RNAFecal-oral; severe in pregnancy
2

Chronicity Risk

  • 1HAV and HEV — acute infection only; do not become chronic.
  • 2HBV — usually resolves in healthy adults, but can become chronic, especially if acquired perinatally or in early childhood.
  • 3HCV — the highest chronicity rate of all hepatitis viruses, frequently progressing silently toward cirrhosis.
✚

Clinical Correlation

READING A HEPATITIS SEROLOGY PANEL

HBsAg positive = currently infected (acute or chronic). Anti-HBs positive (alone) = immune, either from past infection or vaccination. Anti-HBc IgM positive = recent acute infection, useful during the "window period" when HBsAg has cleared but anti-HBs hasn't yet appeared. For Hepatitis C, an anti-HCV antibody-positive result only indicates past exposure — a follow-up HCV RNA test is required to confirm whether the infection is currently active, since the antibody alone cannot distinguish cleared infection from ongoing chronic infection.

2.9  HIV & Retroviruses

1

Structure & Replication

  • HIV is an enveloped retrovirus — its RNA genome is reverse-transcribed into DNA by the viral enzyme reverse transcriptase.
  • The resulting DNA copy integrates into the host cell's chromosome (via integrase), becoming a permanent provirus — this is why HIV infection cannot currently be cured, only controlled.
  • HIV primarily infects CD4+ T helper cells, using CD4 plus a co-receptor (CCR5 or CXCR4) for entry.
2

Disease Progression

StageCD4 CountClinical Picture
Acute infectionTransient drop, then recoversFlu-like illness (fever, rash, lymphadenopathy) 2–4 weeks post-exposure
Chronic/latent phaseGradual decline over yearsOften asymptomatic
AIDS< 200 cells/µLOpportunistic infections (e.g., Pneumocystis pneumonia, disseminated M. avium), AIDS-defining cancers
✚

Clinical Correlation

THE DIAGNOSTIC WINDOW PERIOD

Modern 4th-generation HIV tests detect both antibodies and the p24 antigen, shortening the "window period" (the time after exposure before a test can reliably detect infection) to roughly 2–4 weeks, compared to older antibody-only tests that could take up to 3 months to turn positive — an important consideration when counseling a patient about when to retest after a possible exposure.

📝 🔄 🏠